tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
LYEL
Lyell Immunopharma
RESEARCH TOOLSreports

Lyell Immunopharma (LYEL) Income Statement

153 Followers

Lyell Immunopharma Income Statement

Last quarter (Q4 2025), Lyell Immunopharma's total revenue was $6.00K, a decrease of -45.45% from the same quarter last year. In Q4, Lyell Immunopharma's net income was $-140.72M. See Lyell Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 36.00K$ 61.00K$ 130.00K$ 84.68M$ 10.65M
Gross Profit
$ -11.50M$ 61.00K$ 130.00K$ 84.68M$ 10.65M
Operating Expenses
$ 192.27M$ 358.82M$ 247.14M$ 271.74M$ 225.43M
Depreciation and Amortization
$ 11.54M$ 19.63M$ 20.25M$ 18.02M$ 13.62M
EBITDA
$ -192.24M$ -200.64M$ -226.76M$ -169.04M$ -201.15M
Operating Income
$ -203.77M$ -358.75M$ -247.01M$ -187.06M$ -214.78M
Other Income/Expenses
$ -70.67M$ 15.76M$ 12.38M$ 3.94M$ -35.44M
Pretax Income
$ -274.45M$ -342.99M$ -234.63M$ -183.12M$ -250.22M
Net Income
$ -274.45M$ -342.99M$ -234.63M$ -183.12M$ -250.22M
Per Share Metrics
Basic EPS
$ -16.06$ -1.31$ -0.93$ -0.74$ -1.03
Diluted EPS
$ -16.06$ -1.31$ -0.93$ -0.74$ -1.03
Weighted Average Shares Outstanding
 17.09M 13.07M 12.55M 12.35M 12.14M
Weighted Average Shares Outstanding (Diluted)
 17.09M 13.07M 12.55M 12.35M 12.14M
Currency in USD

Lyell Immunopharma Earnings and Revenue History